Nitroglycerin: Should We Still Ask?

Raymond J. Gibbons

doi:10.7326/0003-4819-139-12-200312160-00014

Nitroglycerin: Should We Still Ask?

Raymond J. Gibbons

Cardiovascular Medicine

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

The study by Henrikson and colleagues in this issue is an important addition to the evidence on the diagnostic value of chest pain relief by nitroglycerin. The response to sublingual nitroglycerin had no diagnostic value in patients who developed chest pain (presumably at rest) under medical supervision after admission. Do these findings mean that we should stop using the response to nitroglycerin to help diagnose patients with chronic chest pain?

Original language	English (US)
Pages (from-to)	1036-1037
Number of pages	2
Journal	Annals of internal medicine
Volume	139
Issue number	12
DOIs	https://doi.org/10.7326/0003-4819-139-12-200312160-00014
State	Published - Dec 16 2003

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-139-12-200312160-00014

Cite this

@article{dbf14c51190f4c9eaeb1c35eefda809c,

title = "Nitroglycerin: Should We Still Ask?",

abstract = "The study by Henrikson and colleagues in this issue is an important addition to the evidence on the diagnostic value of chest pain relief by nitroglycerin. The response to sublingual nitroglycerin had no diagnostic value in patients who developed chest pain (presumably at rest) under medical supervision after admission. Do these findings mean that we should stop using the response to nitroglycerin to help diagnose patients with chronic chest pain?",

author = "Gibbons, {Raymond J.}",

year = "2003",

month = dec,

day = "16",

doi = "10.7326/0003-4819-139-12-200312160-00014",

language = "English (US)",

volume = "139",

pages = "1036--1037",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "12",

}

TY - JOUR

T1 - Nitroglycerin

T2 - Should We Still Ask?

AU - Gibbons, Raymond J.

PY - 2003/12/16

Y1 - 2003/12/16

N2 - The study by Henrikson and colleagues in this issue is an important addition to the evidence on the diagnostic value of chest pain relief by nitroglycerin. The response to sublingual nitroglycerin had no diagnostic value in patients who developed chest pain (presumably at rest) under medical supervision after admission. Do these findings mean that we should stop using the response to nitroglycerin to help diagnose patients with chronic chest pain?

AB - The study by Henrikson and colleagues in this issue is an important addition to the evidence on the diagnostic value of chest pain relief by nitroglycerin. The response to sublingual nitroglycerin had no diagnostic value in patients who developed chest pain (presumably at rest) under medical supervision after admission. Do these findings mean that we should stop using the response to nitroglycerin to help diagnose patients with chronic chest pain?

UR - http://www.scopus.com/inward/record.url?scp=0348134792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0348134792&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-139-12-200312160-00014

DO - 10.7326/0003-4819-139-12-200312160-00014

M3 - Review article

C2 - 14678924

AN - SCOPUS:0348134792

SN - 0003-4819

VL - 139

SP - 1036

EP - 1037

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 12

ER -

Nitroglycerin: Should We Still Ask?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this